16 (S) -HETE

• Description:

  16 (S) -HETE is an endogenous inhibitor of neutrophil activity and can be used in the study of acute ischemic brain injury[1].

• UNSPSC:

  12352211

• Hazard Statement:

  H225-H319

• Target:

  Cytochrome P450

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/16-s-hete.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC(CCC/C=C\C/C=C\C/C=C\C/C=C\[C@@H](O)CCCC)=O

• Molecular Formula:

  C20H32O3

• Molecular Weight:

  320.47

• Precautions:

  P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P370+P378-P403+P235-P501

• References & Citations:

  [1]Reddy Y K, et al. Practical, asymmetric synthesis of 16-hydroxyeicosa-5 (Z), 8 (Z), 11 (Z), 14 (Z) -tetraenoic acid (16-HETE), an endogenous inhibitor of neutrophil activity[J]. Bioorganic & medicinal chemistry letters, 2003, 13 (21) : 3719-3720.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [183509-23-1]